Leadership, management and guidance
The Illawarra Health and Medical Research Institute (IHMRI) is a company limited by guarantee under the Corporations Act 2001. We are also registered as a charity with the Australian Charities and Not-for-profits Commission.
Our founding partners and key stakeholders, the University of Wollongong (UOW) and the Illawarra Shoalhaven Local Health District (ISLHD), engage us to provide research leadership, support, services and infrastructure to grow quality research under four-year funding and service agreements.
In addition both partners provide in-kind support to us to advance the shared vision of improving the health of Illawarra residents through research excellence.
Since 2014, we have been recognised as an independent Medical Research Institute (MRI) by the New South Wales (NSW) State Government, making us eligible for funding from the Medical Research Support Program administered by the Office of Health and Medical Research in the NSW Ministry of Health.
Our patron is renowned scientist Dame Bridget Ogilvie (AC, DBE, ScD, FRS, FAA).
Board of Directors
IHMRI is governed by a Board of Directors comprising three directors each from UOW and ISLHD, as well as three independent directors.
The conduct of IHMRI and the board are guided by the:
- IHMRI Constitution [pdf 180 kb]
- IHMRI Board Charter [pdf 204 kb
- IHMRI Board Code of Conduct [pdf 115 kb]
The IHMRI Chair is appointed by the board from among the independent directors.
Click on the tabs below to view our current Board of Directors.
Professor Alan Pettigrew, Chair
BSc, PhD, FAICD
Consultant and adviser on higher education and research
Emeritus Professor John Rostas
BSc (Hons), PhD
Emeritus Professor, University of Newcastle (independent)
Professor Paul Wellings
CBE, BSc, MSc, PhD, DSc (Hon), FAICD
Vice-Chancellor and Principal
Professor Judy Raper
BE (Hons), PhD, FIEAust, FAATSE, FAICD
Deputy—Vice-Chancellor (Research and Innovation)
Executive Management Team
The IHMRI Executive Director and Chief Executive Officer reports directly to the Board of Directors and provides overall leadership, strategic management and direction for IHMRI.
The Executive Director is assisted in the high-level management of IHMRI’s research program and operations by the Clinical Director, who also acts as IHMRI’s Deputy Executive Director.
Click on the tabs below to read profiles on our Executive Management Team.
Professor David J. Adams
+61 2 4239 2264 firstname.lastname@example.org
Professor David J. Adams joined IHMRI in December 2015 and is former Director of the Health Innovations Research Institute at the Royal Melbourne Institute of Technology University.
He was an ARC Australian Professorial Fellow from 2010 to 2015 and was previously Professor and Chair of Physiology at the University of Queensland, Head of Department of Physiology & Pharmacology (1998-2000), Head of the School of Biomedical Sciences (2000-07) and Professorial Research Fellow in the Queensland Brain Institute (2008-09).
He is a Chief Investigator on an NHMRC Program Grant (2005-2019) to identify novel pain therapeutics based on venom peptides (conotoxins) from cone snails. He has published over 180 refereed journal articles (112 as first or senior author) in leading journals and 16 book chapters. He has been principal supervisor and co-supervisor of more than 30 PhD students.
Professor Adams is the past President of the Australian Physiological Society, a former member of the National Committee for Biomedical Science, Australian Academy of Science and a member of five Editorial Boards of international scientific journals. He is currently a member of NHMRC Assigners Academy and a member of the Research Management Council for Multiple Sclerosis Research Australia.
Professor Leonard Arnolda
+61 2 4221 4307 email@example.com
In January 2016, Professor Leonard Arnolda was appointed IHMRI’s inaugural Clinical Director – a new leadership role shared between IHMRI and the Illawarra Shoalhaven Local Health District (ISLHD) to encourage and support clinical research in the region and facilitate collaborations between IHMRI-affiliated academic and clinician researchers.
Professor Arnolda obtained his PhD from Monash University where he studied the role of vasopressin in heart failure. He was then a Commonwealth Medical Fellow and National Health and Medical Research Council Neil Hamilton Fairley Fellow at Oxford University (UK), where he studied skeletal muscle metabolism in heart failure.
Returning to Australia, he accepted a post at the Flinders Medical Centre in South Australia, working there until 2001 until he moved to Perth to take up the role of Professor of Cardiology at the Royal Perth Hospital (RPH), where he served terms as both head of the hospital’s Cardiology Department and head of the RPH’s unit of the University Department of Medicine. In 2009 he was appointed Director of Cardiology at ACT Health and Professor of Cardiology at the Australian National University.
Professor Arnolda is an active researcher whose work spans basic laboratory science and clinical research and involves investigations on the physiology of the heart and circulation in health and its pathophysiology, as manifest in diseases such as heart failure and high blood pressure. He currently chairs the National Blood Pressure and Vascular Disease Advisory Committee for the National Heart Foundation and the Hypertension working group of the Cardiac Society of Australia and New Zealand.
+61 2 4252 8941 firstname.lastname@example.org
Ms Lamond was appointed as Chief Operating Officer in August 2016 and is responsible for the general management of IHMRI’s governance, communications, planning, finances and infrastructure. With senior-level experience in both the public and private sectors, Ms Lamond has led major reforms and initiatives in service delivery and infrastructure management.
Her most recent positions include Executive Manager of Strategy, Planning and Innovation at the NSW State Emergency Services, and Executive Director at Migration Law Australia. Ms Lamond also gained extensive experience leading health and justice projects as Senior Manager for the NSW Department of Premier and Cabinet.
She holds a Master of Business Administration and a Bachelor of Arts from the University of Wollongong. She also has a Graduate Law degree from the Australian National University and a Bachelor of Urban and Regional Planning from the University of New England.
The Scientific Advisory Committee (SAC) provides advice on IHMRI’s research priorities and research strengths, as well as guidance on funding opportunities.
The SAC also participates in reviews of research initiatives and provides a broad perspective of national and international trends in health and medical research.
The SAC consists of up to eight members, including IHMRI’s Executive Director and Clinical Director, and external members who serve for an initial term of three years. Drawn from a range of external Australiasian institutions and universities, the external committee members are highly successful and experienced international researchers.
Professor Robin Anderson
Head, Translational Breast Cancer Program, Olivia Newton John Cancer Research Institute
Professor Perry Bartlett
Director, Queensland Brain Institute, University of Queensland
Professor David Craik
Institute for Molecular Bioscience, University of Queensland
Professor Christos Pantelis
Scientific Director, Melbourne Neuropsychiatry Centre, University of Melbourne and Melbourne Health
Our multidisciplinary researchers work within and across three broad research themes. Each theme contains a broad cross-section of researchers, from those involved in basic science, through to researchers working in clinical, population and public health.
IHMRI research themes organise activities to bring diverse researchers together to promote collaborative research opportunities. In 2017 IHMRI appointed new theme leaders for 2017-19. Each theme is facilitated by a scientific leader and a clinical leader.
Researchers in this theme explore the fundamental mechanisms of disease. They use this knowledge to design, test and evaluate new drugs, as well as medical devices. They work together to increase treatment options and quality of life for patients with complex medical conditions.
Dr Martina Sanderson-Smith
Centre for Medical and Molecular Bioscience, School of Biology, University of Wollongong
Clinical Professor Spiros Miyakis
Acting Director of Infectious Diseases, Wollongong Hospital / Staff Specialist in Medicine and Infectious Diseases, Illawarra Shoalhaven Local Health District School of Medicine, University of Wollongong
Researchers in this theme examine the mechanisms, causes, prevention and treatment of a wide range of chronic and complex psychiatric illnesses, neurodegenerative diseases and neurodevelopmental disorders. Together they seek to address the burden of mental illness and neurodegenerative diseases in the region.
Associate Professor Heath Ecroyd
Centre for Medical and Molecular Bioscience, School of Biology, University of Wollongong
Distinguished Professor Xu-Feng Huang
Director, Centre for Translational Neuroscience, School of Medicine, University of Wollongong
Researchers in this theme study the links between disease and lifestyle risk factors, such as excess weight, poor diet, high blood pressure, drug addictions and physical inactivity. They work together to find better treatments and prevention strategies to extend healthy ageing.
Professor Barbara Meyer
Director, Lipid Research Centre, School of Medicine, University of Wollongong
Professor Ian Wright
Professor of Paediatrics, Illawarra Shoalhaven Local Health District Paediatrics and Child Health Research, School of Medicine, University of Wollongong